Published in Br J Pharmacol on December 01, 1998
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data. Psychopharmacology (Berl) (2003) 1.66
Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol (2002) 1.53
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol (2008) 1.41
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. Neuropharmacology (2007) 1.35
Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice. AAPS J (2009) 1.31
FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. Neuropsychopharmacology (2010) 1.25
The analgesic potential of cannabinoids. J Opioid Manag (2010) 1.16
Self-administration of cannabinoids by experimental animals and human marijuana smokers. Pharmacol Biochem Behav (2005) 1.01
Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum. Mol Pharmacol (2004) 1.00
Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. Int Rev Psychiatry (2009) 0.98
Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction. Br J Pharmacol (2001) 0.97
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol. Drug Alcohol Depend (2008) 0.96
Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future. Front Psychiatry (2014) 0.93
Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction. Pharmacol Ther (2013) 0.92
Dissociation of the pharmacological effects of THC by mTOR blockade. Neuropsychopharmacology (2013) 0.90
Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure. J Clin Invest (2013) 0.88
Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.87
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects. Neuropsychopharmacology (2015) 0.87
Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze. Neurosci Lett (2010) 0.86
Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system. Cold Spring Harb Perspect Med (2013) 0.86
Animal models of cannabinoid reward. Br J Pharmacol (2010) 0.84
Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice. Br J Pharmacol (2004) 0.84
Cannabinoid exposure during zebra finch sensorimotor vocal learning persistently alters expression of endocannabinoid signaling elements and acute agonist responsiveness. BMC Neurosci (2011) 0.83
Drug addiction. Curr Top Behav Neurosci (2009) 0.81
delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory. Psychopharmacology (Berl) (2011) 0.80
MDMA attenuates THC withdrawal syndrome in mice. Psychopharmacology (Berl) (2007) 0.80
Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497. J Basic Clin Physiol Pharmacol (2016) 0.80
Cannabinoid conditioned reward and aversion: behavioral and neural processes. ACS Chem Neurosci (2010) 0.79
Cannabinoids modulate ultrasound-induced aversive responses in rats. Psychopharmacology (Berl) (2003) 0.78
Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist. Psychopharmacology (Berl) (2015) 0.76
Marijuana dependence: not just smoke and mirrors. ILAR J (2011) 0.76
Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210. Biomol Ther (Seoul) (2015) 0.75
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature (1996) 7.15
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (1999) 4.31
First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J Mol Biol (1995) 3.63
Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet (2000) 3.10
Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci (2000) 3.09
The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med (2000) 2.62
Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature (2000) 2.57
Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology (1990) 2.47
Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR. EMBO J (1992) 2.21
Increase of oleic acid in erythrocytes associated with malignancies. Br Med J (Clin Res Ed) (1985) 2.15
The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature (1980) 2.13
Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med (2001) 2.07
Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science (1996) 2.01
Basic amino acids flanking the zinc finger of Moloney murine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity. J Virol (1993) 1.91
First large scale chemical synthesis of the 72 amino acid HIV-1 nucleocapsid protein NCp7 in an active form. Biochem Biophys Res Commun (1991) 1.88
High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature (1978) 1.87
DNA Bifunctional intercalators. 2. Fluorescence properties and DNA binding interaction of an ethidium homodimer and an acridine ethidium heterodimer. Biochemistry (1978) 1.86
Ethidium dimer: a new reagent for the fluorimetric determination of nucleic acids. Anal Biochem (1979) 1.81
Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci (2001) 1.78
Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am J Physiol Renal Physiol (2000) 1.77
Carcinoma in choledochal cysts. Age-related incidence. Arch Surg (1983) 1.75
Two rotameric forms of open ring 7-methylguanine are present in alkylated polynucleotides. Nucleic Acids Res (1984) 1.74
International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev (1999) 1.74
NCp7 activates HIV-1Lai RNA dimerization by converting a transient loop-loop complex into a stable dimer. J Biol Chem (1996) 1.73
Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature (1997) 1.72
NMR structure of the HIV-1 regulatory protein VPR. J Mol Biol (2003) 1.64
Neural substrates of opiate withdrawal. Trends Neurosci (1992) 1.52
Molecular cloning and nucleotide sequence of rat kidney gamma-glutamyl transpeptidase cDNA. Proc Natl Acad Sci U S A (1986) 1.52
DNA bifunctional intercalators. I. Synthesis and conformational properties of an ethidium homodimer and of an acridine ethidium heterodimer. Biochemistry (1978) 1.51
Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR. J Mol Biol (1994) 1.49
Solid phase synthesis of the retroviral nucleocapsid protein NCp10 of Moloney murine leukaemia virus and related "zinc-fingers" in free SH forms. Influence of zinc chelation on structural and biochemical properties. Int J Pept Protein Res (1990) 1.48
Effect of haemodilution on transfusion requirements in liver resection. Lancet (1989) 1.46
Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain. Eur J Pain (2012) 1.42
Guanine nucleotide inhibition of cyc- S49 mouse lymphoma cell membrane adenylyl cyclase. J Biol Chem (1982) 1.42
[Hysteria epidemics, epidemic conversion disorder or epidemic somatotrophic disorders?: a new case of a fact for the 21st century]. Aten Primaria (2000) 1.41
Expression of neutral endopeptidase (enkephalinase) in heterologous COS-1 cells. Characterization of the recombinant enzyme and evidence for a glutamic acid residue at the active site. J Biol Chem (1988) 1.40
Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid protein. Biopolymers (1997) 1.39
Nucleic acid sequence discrimination by the HIV-1 nucleocapsid protein NCp7: a fluorescence study. Biochemistry (1999) 1.39
Human immunodeficiency virus type 1 nucleocapsid protein specifically stimulates Mg2+-dependent DNA integration in vitro. J Virol (1997) 1.37
Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur J Neurosci (2001) 1.35
Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor. J Neurosci (1998) 1.35
DNA intercalating compounds as potential antitumor agents. 2. Preparation and properties of 7H-pyridocarbazole dimers. J Med Chem (1980) 1.34
A role for cannabinoid CB1 receptors in mood and anxiety disorders. Behav Pharmacol (2005) 1.33
Pre- and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res (1990) 1.33
Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice. J Neurosci (2001) 1.33
Studies on the effect of cortisone on rat liver transfer ribonucleic acid. Biochemistry (1969) 1.33
Progesterone inhibits membrane-bound adenylate cyclase in Xenopus laevis oocytes. Nature (1981) 1.32
Proteolytic activation of rat liver adenylate cyclase by a contaminant of crude collagenase from Clostridium histolyticum. J Biol Chem (1977) 1.30
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology (2002) 1.29
Genome annotation and comparative analyses of the odorant-binding proteins and chemosensory proteins in the pea aphid Acyrthosiphon pisum. Insect Mol Biol (2010) 1.28
The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins. FEBS Lett (1993) 1.27
Evidence of interactions between the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1. J Biol Chem (1999) 1.27
Involvement of HIV-I nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. J Biol Chem (1998) 1.26
Conformation of Met5-enkephalin determined by high field PMR spectroscopy. Nature (1976) 1.26
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci U S A (1996) 1.26
Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci (2000) 1.25
Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain. J Neurochem (1997) 1.25
Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod (2010) 1.25
Mice with very low expression of the vesicular monoamine transporter 2 gene survive into adulthood: potential mouse model for parkinsonism. Mol Cell Biol (2001) 1.24
Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors. Biochem Biophys Res Commun (1983) 1.23
NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions. J Mol Biol (1999) 1.23
A high affinity calcium-stimulated magnesium-dependent ATPase in rat liver plasma membranes. Dependence of an endogenous protein activator distinct from calmodulin. J Biol Chem (1981) 1.22
Regulation of adenylate cyclase of human platelet membranes by forskolin. J Biol Chem (1982) 1.22
Properties and growth mechanism of the ordered aggregation of a model RNA by the HIV-1 nucleocapsid protein: an electron microscopy investigation. Biopolymers (1998) 1.22
Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res Mol Brain Res (2001) 1.22
High-throughput fluorogenic assay for determination of botulinum type B neurotoxin protease activity. Anal Biochem (2001) 1.21
Hepatectomy without abdominal drainage. Results of a prospective study in 61 patients. Ann Surg (1989) 1.19
A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl) (2000) 1.18
Improved early results of elective hepatic resection for liver tumors. One hundred consecutive hepatectomies in cirrhotic and noncirrhotic patients. Arch Surg (1989) 1.18
Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis (2000) 1.16
Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif (2008) 1.16
D-Tyr--Ser-Gly--Phe--Leu--Thr, a highly preferential ligand for delta-opiate receptors. FEBS Lett (1980) 1.15
Structure of the complex between the HIV-1 nucleocapsid protein NCp7 and the single-stranded pentanucleotide d(ACGCC). J Mol Biol (1998) 1.14
Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation. Eur J Pharmacol (1992) 1.14
The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J Biol Chem (1997) 1.14
CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology. Prog Neurobiol (1999) 1.14
Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience (2005) 1.14
NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos. Nat Struct Biol (1994) 1.13
Isolation of adenylate cyclase-free, beta-adrenergic receptor from turkey erythrocyte membranes by affinity chromatography. Proc Natl Acad Sci U S A (1977) 1.13
The annealing of tRNA3Lys to human immunodeficiency virus type 1 primer binding site is critically dependent on the NCp7 zinc fingers structure. J Biol Chem (1998) 1.11
Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci U S A (1999) 1.11
Genetic analysis of drug addiction: the role of cAMP response element binding protein. J Mol Med (Berl) (1998) 1.10
The olfactory adenylyl cyclase type 3 is expressed in male germ cells. FEBS Lett (1998) 1.09
Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur J Neurosci (2001) 1.08
Identification of glutamic acid 646 as a zinc-coordinating residue in endopeptidase-24.11. J Biol Chem (1991) 1.08
Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization. Br J Pharmacol (2012) 1.07
A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity. FASEB J (1999) 1.07
Primary structure homologies between two zinc metallopeptidases, the neutral endopeptidase 24.11 ("enkephalinase") and thermolysin, through clustering analysis. Biochemistry (1988) 1.07
Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J Neurochem (1997) 1.07